UY36444A - Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método - Google Patents

Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método

Info

Publication number
UY36444A
UY36444A UY0001036444A UY36444A UY36444A UY 36444 A UY36444 A UY 36444A UY 0001036444 A UY0001036444 A UY 0001036444A UY 36444 A UY36444 A UY 36444A UY 36444 A UY36444 A UY 36444A
Authority
UY
Uruguay
Prior art keywords
pharmaceutical administration
administration system
calcium carbonate
producing
system obtained
Prior art date
Application number
UY0001036444A
Other languages
English (en)
Inventor
Stirnimann Tanja
Atria Susanna
Puchkov Maxim
Huwyler Jörg
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of UY36444A publication Critical patent/UY36444A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Abstract

La presente invención se refiere a un método para la producción de un sistema de administración farmacéutica, al uso de un carbonato de calcio reaccionado en superficie para mejorar la friabilidad de un sistema de administración farmacéutica al igual que para mejorar la capacidad de flujo de un sistema de administración farmacéutica, y a un sistema de administración farmacéutica obtenido por el método.
UY0001036444A 2014-12-18 2015-12-16 Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método UY36444A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14199037.4A EP3034070A1 (en) 2014-12-18 2014-12-18 Method for the production of a pharmaceutical delivery system
US201462095865P 2014-12-23 2014-12-23
US201562232516P 2015-09-25 2015-09-25

Publications (1)

Publication Number Publication Date
UY36444A true UY36444A (es) 2016-04-29

Family

ID=52338877

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036444A UY36444A (es) 2014-12-18 2015-12-16 Método para producir sistema de administración farmacéutica, uso de carbonato de calcio y sistema de administración farmacéutica obtenido por método

Country Status (18)

Country Link
US (1) US20190022012A1 (es)
EP (2) EP3034070A1 (es)
JP (1) JP2017538733A (es)
KR (1) KR20170098894A (es)
CN (1) CN107106498A (es)
AR (1) AR103077A1 (es)
AU (1) AU2015367524B2 (es)
BR (1) BR112017012665A2 (es)
CA (1) CA2969763A1 (es)
CO (1) CO2017005500A2 (es)
CR (1) CR20170236A (es)
MX (1) MX2017007880A (es)
PH (1) PH12017501035A1 (es)
RU (1) RU2693491C2 (es)
SG (1) SG11201704513VA (es)
TW (1) TW201627009A (es)
UY (1) UY36444A (es)
WO (1) WO2016096997A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
EP3260114A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260115A1 (en) 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
EP3275537A1 (en) 2016-07-25 2018-01-31 Omya International AG Surface-modified calcium carbonate as carrier for transition metal-based catalysts
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
JP2022537105A (ja) 2019-06-17 2022-08-24 ディーエスエム アイピー アセッツ ビー．ブイ． メトホルミンＨＣｌ、ビタミンＢ１２、及び少なくとも１つの流動性添加物を含む組成物
US20210059932A1 (en) * 2019-08-28 2021-03-04 Vincent Langlois Multi-layer edible strip containing active medicinal ingredients
CN111419815B (zh) * 2020-04-23 2022-03-11 永信药品工业（昆山）股份有限公司 依托考昔片及其优化方法
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒
EP3928859A1 (en) 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
CN113413388B (zh) * 2021-06-30 2022-11-15 上海奥全生物医药科技有限公司 含有枸橼酸西地那非的药物组合物、制备方法及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (es) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
DK162986A (da) 1985-04-12 1986-10-13 Forest Laboratories Terapeutisk middel i enhedsdosisform
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
WO1995005809A1 (fr) 1993-08-20 1995-03-02 Nippon Shinyaku Co., Ltd. Preparation restant dans l'estomac, forme moulee gonflee, et procede de preparation
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
EP1175899B1 (fr) * 2000-07-27 2007-08-29 Roquette FrÀ¨res Granules à base d'amidon et de lactose
CN1264574C (zh) * 2000-09-06 2006-07-19 田边制药株式会社 口服制剂
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2881957B1 (fr) * 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
ES2352298T3 (es) 2007-12-12 2011-02-17 Omya Development Ag Proceso para realizar carbonato cálcico precipitado tratado superficialmente.
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
ATE542862T1 (de) 2009-06-15 2012-02-15 Omya Development Ag Verfahren zur herstellung von oberflächenreaktivem kalziumkarbonat und verwendung
RS52297B (en) 2009-06-15 2012-12-31 Omya Development Ag PROCEDURE FOR OBTAINING SURFACE CARBONATE CALCIUM BY THE APPLICATION OF LOW ACID
PT2679638E (pt) 2012-06-28 2015-11-09 Omya Int Ag Suspensão aquosa de mineral e/ou carga e/ou pigmento com alto teor de sólidos em ambiente de ph
PL2719373T3 (pl) * 2012-10-12 2017-10-31 Omya Int Ag Preparat szybko rozpadającej się stałej postaci dawkowanej zawierający funkcjonalizowany węglan wapnia i sposób ich wytwarzania
HUE025008T2 (en) * 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
PT2810656T (pt) * 2013-06-06 2017-11-13 Zentiva As Formulações de agomelatina compreendendo agomelatina na forma de cocristais
RU2646113C1 (ru) * 2016-09-06 2018-03-01 Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) Способ получения системы доставки фрагментов нуклеиновых кислот в клетки млекопитающих

Also Published As

Publication number Publication date
EP3034070A1 (en) 2016-06-22
JP2017538733A (ja) 2017-12-28
MX2017007880A (es) 2017-09-05
CA2969763A1 (en) 2016-06-23
RU2017125320A3 (es) 2019-01-18
CN107106498A (zh) 2017-08-29
CO2017005500A2 (es) 2017-09-29
PH12017501035A1 (en) 2018-03-05
US20190022012A1 (en) 2019-01-24
CR20170236A (es) 2017-09-26
AU2015367524B2 (en) 2018-03-15
AU2015367524A1 (en) 2017-07-20
TW201627009A (zh) 2016-08-01
EP3233062A1 (en) 2017-10-25
BR112017012665A2 (pt) 2017-12-26
AR103077A1 (es) 2017-04-12
SG11201704513VA (en) 2017-07-28
RU2693491C2 (ru) 2019-07-03
KR20170098894A (ko) 2017-08-30
RU2017125320A (ru) 2019-01-18
WO2016096997A1 (en) 2016-06-23

Similar Documents

Publication Publication Date Title
CO2017005500A2 (es) Método para la producción de un sistema de administración farmacéutica
BR112018073384A2 (pt) polinucleotídeos moduladores
PH12016502586A1 (en) Lipid comprising docosapentaenoic acid
CR20160450A (es) Anticuerpos multiespecificos
UY34144A (es) ?proceso para la producción de carbonato de calcio precipitado, carbonato de calcio precipitado y sus usos
BR112016012129A8 (pt) métodos para produção, expansão e purificação de células epiteliais do pigmento da retina, composição farmacêutica e uso das células
ES2897914T8 (es) Compuestos que contienen nitrógeno, adecuados para el uso en la producción de poliuretanos
CO2017002472A2 (es) Formulación de acetato de abiraterona
CL2016003054A1 (es) Método para la producción de gránulos que comprenden carbonato de calcio de reacción superficial.
BR112016018654A2 (pt) Composições de silicato estabilizadas e seu uso como composições antiperspirantes
GT201700058A (es) Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos
BR112018010605A2 (pt) nanoemulsões de bebidas produzidas por processamento de alto cisalhamento
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
UY35986A (es) Método mejorado para la producción de extractos de ginkgo
BR112017001391A2 (pt) componentes para o fusionamento de corpos vertebrais
CY1120812T1 (el) Υποκατεστημενα παραγωγα αζασπειρο(4.5)δεκανιου
BR112017009205A2 (pt) método para preparar bifenilaminas a partir de azobenzenos por catálise de rutênio
UY36064A (es) Derivados quirales de ácido ciclopentancarboxílico 2,5-disustituidos y su uso
BR112016028083A2 (pt) Composição oral farmacêutica de isotretinoina e seu processo de preparação
DOP2017000264A (es) Metodo para crear un compuesto a base de mercurio, compuesto a base de mercurio, metodos de uso del compuesto a base de mercurio y usos del compuesto a base de mercurio
BR112016023767A2 (pt) forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações
BR112015027977A2 (pt) método para a produção de formulações de óleo, formulações de óleo, e uso das formulações de óleo
AR103779A1 (es) Proceso para la producción de carbonato de calcio precipitado de alto contenido de sólidos con aditivo catiónico
BR112017010403A2 (pt) método para a produção de praziquantel
MY175821A (en) Microorganism having ability to produce o-succinylhomoserine or succinic acid, and method for producing succinic acid or o-succinylhomoserine by using same

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220712